Navigation Links
MedQuist Reports Second Quarter 2008 Results
Date:8/8/2008

MOUNT LAUREL, N.J., Aug. 8 /PRNewswire-FirstCall/ -- MedQuist Inc.,(Nasdaq: MEDQ) the largest Medical Transcription Service Organization (MTSO) in the world, today announced its results for the quarter ended June 30, 2008. Revenue for the second quarter of 2008 was $82.5 million compared with $88.7 million in the second quarter of 2007. The decrease in revenue of $6.2 million or 7% from the prior year period was primarily due to customer losses experienced during the second half of 2007. Operating income for the quarter decreased to $1.8 million compared to operating income of $4.2 million in the second quarter of 2007. Operating income in the second quarter of 2007 was positively impacted by the recognition of $11.9 million of insurance recoveries which were exhausted by the end of 2007.

Non-GAAP Operating income (excluding the cost of the billing investigation and legal proceedings, net) increased by $6.1 million to $3.6 million in the second quarter of 2008 compared to a non-GAAP operating loss of $2.5 million in the second quarter of 2007. "This improvement reflects the significant progress we have made in streamlining both our fixed and variable cost structures. In addition, notable orders in the quarter included multimillion dollar outsourced transcription expansions at two leading academic medical center customers and the return of a large midwestern academic medical center customer who had left us in 2004," said Mark Ivie, the company's Interim President and Chief Executive Officer.

Cost of revenue was reduced by $8.3 million or 13% to $58.0 million in the second quarter of 2008 compared to $66.3 million in the second quarter of 2007. This resulted in a decrease in cost of revenue as a percentage of revenue to 70% co
'/>"/>

SOURCE MedQuist, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. MedQuist Announces Changes to Board of Directors
2. MedQuist Announces Declaration of $2.75 per share Dividend on Common Stock
3. Award-Winning Massachusetts Hospital Selects MedQuist Enterprise Technology for Clinical Documentation and Speech Recognition
4. MedQuist Announces Dismissal of South Broward Litigation and Appointment of New Interim President & CEO
5. MedQuist to Get New Majority Stakeholder
6. MedQuist Technology Solutions to Power Documentation Workflow at New England Facility
7. MedQuist Announces Entry Into Settlement Term Sheet Resolving South Broward Litigation
8. Leading Arizona Radiological Group Selects MedQuist for Speech Recognition Solution
9. MedQuist Announces Appointment of Brian ODonoghue and Mark E. Schwarz to its Board of Directors
10. MedQuist Files Preliminary Proxy Statement and Applies for Listing on NASDAQ
11. MedQuist Evaluating Whether a Sale of the Company is in the Best Interests of the Company and its Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... Unveiled at the Sept. 18 board meeting, The Center ... hospital ROI on membership dues at 12.5. In other words, ... in value to member hospitals. The calculation used to determine ... , “This is the first time we’ve actually been ... methodology is really sound,” said Bill Ryan , president ...
(Date:10/20/2014)... Do you ever feel difficulty in ... wonderful app Metassessor for teachers, specialists and parents. SIMpalm, ... its client “Intervention Development LLC” to launch Metassessor App ... for iOS 4.3 or later and is Compatible with ... for iPhone 5. It is now available on Apple ...
(Date:10/19/2014)... Dr. Babatunde Osotimehin, Executive Director of ... a ceasefire agreement that is expected to lead to ... were kidnapped from the north-eastern Nigerian town of Chibok—the ... enough, and it is high time they are returned ... , "We owe it to these girls to positively ...
(Date:10/19/2014)... Recently, Fancyflyingfox.com, an innovative company that ... announced its latest designs of 2014 mother of ... elegant outfits are offered with big discounts, up to ... October 30 can enjoy this special offer. , ... it has become one of the leading brands in ...
(Date:10/19/2014)... 19, 2014 (HealthDay News) -- New stem cell-based research ... to new treatments, a new study suggests. Scientists ... intestinal tissue in a lab dish. They then transplanted ... studying intestinal disorders, according to the researchers. "This ... and conditions that can cause intestinal failure, from genetic ...
Breaking Medicine News(10 mins):Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3Health News:Fancyflyingfox.com Updates Its Website With New Mother Of The Bride Dresses For 2014 2Health News:Scientists Grow, Implant Human Intestinal Tissue in Mice 2
... detection system finds cavities before X-rays allowing, ... filling required, TORONTO, July 3 /PRNewswire/ - ... its breakthrough technology which,detects and monitors the early ... x-rays. It reduces the number of invasive and ...
... Utah, July 3 Nu Skin Enterprises, Inc.,(NYSE: ... presenting at the,Oppenheimer Consumer Growth Conference in Boston on ... webcast live beginning at 2:55 p.m.,(EST). Those wishing to ... Nu Skin Enterprises, website, at, http://www.nuskinenterprises.com . The archive ...
... DETROIT, July 2 The Michigan Attorney General announced,on ... Cross Blue Shield of,Michigan challenging a capital transaction between ... taken the position that BCBSM is not,authorized by Public ... in fact, Accident Fund obtained prior regulatory approval for ...
... General Hospital (MGH) investigators have shown that an MGH-developed, ... the bloodstream can be used to determine the genetic ... for targeted treatment and monitoring genetic changes that occur ... called the CTC-chip will appear in the July 24 ...
... light of today,s,announcement that Attorney General Mike Cox is ... the Coalition for a Fair and,Competitive Insurance Market is ... Blue Cross Blue Shield of Michigan (BCBSM) to use ... and insurance., "We were confident when we raised ...
... individual patients, study says , , WEDNESDAY, July 2 (HealthDay News) ... cells in the blood of lung cancer patients may make ... the genetic "signature" of particular tumors but to monitor changes ... think this is key to personalized medicine," said Dr. Daniel ...
Cached Medicine News:Health News:Breakthrough Technology That Will Revolutionize the Treatment of Tooth Decay 2Health News:Breakthrough Technology That Will Revolutionize the Treatment of Tooth Decay 3Health News:Circulating tumor cells can reveal genetic signature of dangerous lung cancers 2Health News:Circulating tumor cells can reveal genetic signature of dangerous lung cancers 3Health News:Coalition Calls on MI Legislature to Abandon Blue Cross Legislation 2Health News:Circulating Tumor Cells Reveal Insights Into Lung Cancers 2Health News:Circulating Tumor Cells Reveal Insights Into Lung Cancers 3
(Date:10/20/2014)... SAN DIEGO , Oct. 20, 2014 /PRNewswire/ ... development of therapeutic antibodies, today announced the appointment ... Development Officer. Dr. Londei will lead the preclinical ... "We are pleased to welcome ... Hamza Suria , President and Chief Executive ...
(Date:10/20/2014)... , Oct. 20, 2014 Lpath, ... leader in bioactive lipid-targeted therapeutics, received official notification from ... been granted another key patent supporting its iSONEP™ ... issued patent, European patent No. 2087002, claims compositions ... in Lpath,s two lead compounds, iSONEP and ASONEP. ...
(Date:10/20/2014)... , Oct. 20, 2014   Mary,s Medicinals ... for Caring, is a 4-Star Sponsor of Operation ... Veterans with unique products, programs and services to assist ... freedom. Key Facts: , An ... is a safe and effective treatment for pain, Post-traumatic ...
Breaking Medicine Technology:AnaptysBio Appoints Dr. Marco Londei to Newly Created Chief Development Officer Position Clinical Immunologist to Lead AnaptysBio's Pipeline Advancement 2Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 2Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 3Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 4Mary's Medicinals Announces 4-Star Sponsorship of Operation Grow4Vets 2Mary's Medicinals Announces 4-Star Sponsorship of Operation Grow4Vets 3
... Healthcare Products, Inc., (NASDAQ: AHPI ) reported ... hospitals and government entities still suffering from recession-driven budget cuts. ... per basic and diluted share, for the 2011 fiscal year compared ... per share, for the previous year. For the quarter, ...
... Sept. 2, 2011 Sigma-Aldrich Corporation (NASDAQ: ... conferences in September: KeyBanc Capital Markets ... 13, at the InterContinental, Boston, MA, presenting at 9:00 ... Wednesday, September 14, at the Grand Hyatt, New York, ...
Cached Medicine Technology:Allied Healthcare Reports Profitable Quarter and Year Despite Lingering Effects of Recession 2Allied Healthcare Reports Profitable Quarter and Year Despite Lingering Effects of Recession 3Allied Healthcare Reports Profitable Quarter and Year Despite Lingering Effects of Recession 4Sigma-Aldrich Corporation to Present at Upcoming Investor Conferences 2
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
... Hamilton is precision, ergonomics, and ... hand fatigue with soft non-slip, contoured ... with smooth, light plunger spring action ... and sterilization without the need for ...
This fixed-volume digital micropipet is used to accurately measure and transfer 20 microliters of solution....
... The Research Family includes fixed-volume, ... as the electronic Eppendorf Research pro ... button, these compact, high-performance pipettes have ... Optimally suited for use with original ...
Medicine Products: